LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | BI-2536 | 10.0 | uM | LJP6 | 72 | hr | 929 | 991 | 3228 | 0.3072 | 0.0272 |
Hs 578T | BMS345541 | 10.0 | uM | LJP6 | 72 | hr | 929 | 804 | 3228 | 0.2493 | -0.0542 |
Hs 578T | SNS-032 | 10.0 | uM | LJP6 | 72 | hr | 929 | 800 | 3228 | 0.2478 | -0.0562 |
Hs 578T | GDC-0980 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1198 | 3228 | 0.3712 | 0.1171 |
Hs 578T | NVP-AEW541 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1693 | 3228 | 0.5246 | 0.3324 |
Hs 578T | SB590885 | 10.0 | uM | LJP5 | 72 | hr | 929 | 2977 | 3228 | 0.9222 | 0.8908 |
Hs 578T | PIK-93 | 10.0 | uM | LJP5 | 72 | hr | 929 | 1354 | 3228 | 0.4197 | 0.1851 |
Hs 578T | KIN001-043 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1794 | 3228 | 0.5558 | 0.3762 |
Hs 578T | Alpelisib | 10.0 | uM | LJP5 | 72 | hr | 929 | 2115 | 3228 | 0.6553 | 0.5160 |
Hs 578T | Luminespib | 10.0 | uM | LJP5 | 72 | hr | 929 | 1302 | 3228 | 0.4034 | 0.1623 |
Hs 578T | A443654 | 10.0 | uM | LJP6 | 72 | hr | 929 | 684 | 3228 | 0.2119 | -0.1067 |
Hs 578T | OSI-027 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1356 | 3228 | 0.4201 | 0.1856 |
Hs 578T | XMD11-85h | 10.0 | uM | LJP6 | 72 | hr | 929 | 1611 | 3228 | 0.4991 | 0.2966 |
Hs 578T | HG-6-64-01 | 10.0 | uM | LJP6 | 72 | hr | 929 | 682 | 3228 | 0.2114 | -0.1074 |
Hs 578T | WH-4-025 | 10.0 | uM | LJP5 | 72 | hr | 929 | 617 | 3228 | 0.1912 | -0.1357 |
Hs 578T | WZ-4-145 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1275 | 3228 | 0.3952 | 0.1507 |
Hs 578T | XMD16-144 | 10.0 | uM | LJP5 | 72 | hr | 929 | 832 | 3228 | 0.2577 | -0.0423 |
Hs 578T | Brivanib | 10.0 | uM | LJP5 | 72 | hr | 929 | 2759 | 3228 | 0.8548 | 0.7961 |
Hs 578T | Buparlisib | 10.0 | uM | LJP5 | 72 | hr | 929 | 657 | 3228 | 0.2036 | -0.1183 |
Hs 578T | BX-912 | 10.0 | uM | LJP5 | 72 | hr | 929 | 934 | 3228 | 0.2895 | 0.0024 |
Hs 578T | Canertinib | 10.0 | uM | LJP6 | 72 | hr | 929 | 609 | 3228 | 0.1889 | -0.1390 |
Hs 578T | Celastrol | 10.0 | uM | LJP6 | 72 | hr | 929 | 564 | 3228 | 0.1749 | -0.1586 |
Hs 578T | CGP60474 | 10.0 | uM | LJP5 | 72 | hr | 929 | 788 | 3228 | 0.2441 | -0.0614 |
Hs 578T | CGP60474 | 10.0 | uM | LJP6 | 72 | hr | 929 | 669 | 3228 | 0.2074 | -0.1131 |
Hs 578T | CHIR-99021 | 10.0 | uM | LJP6 | 72 | hr | 929 | 1986 | 3228 | 0.6152 | 0.4597 |